Latest News about ALNY
Recent news which mentions ALNY
34 Stocks Moving In Monday's Mid-Day Session
December 27, 2021
From Benzinga
FDA Approves Alnylam - Novartis' Leqvio As the First siRNA To Reduce Bad Cholesterol
December 23, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
December 23, 2021
From Benzinga
From Benzinga
2 Mid-Cap Biopharma Stocks BofA Securities Recommends For 2022
December 14, 2021
From Benzinga
3 Under-the-Radar Biotech Stocks to Buy in 2022
December 11, 2021
From Motley Fool
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
Why Arbutus Biopharma Is Rocketing Higher Today
December 01, 2021
From Motley Fool
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
November 23, 2021
From Motley Fool
Read Why Analysts Are Going Bullish On This Large-Cap Pharma Stock
November 22, 2021
Tickers
ALNY
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021
November 22, 2021
From Benzinga
10 Biggest Price Target Changes For Monday
November 22, 2021
From Benzinga
From Benzinga
Why Dicerna Pharmaceuticals Stock Is Rocketing Higher Today
November 18, 2021
From Motley Fool
3 Vaccine Stocks With Big Opportunities Outside of COVID-19
November 11, 2021
From Motley Fool
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
Alnylam Pharmaceuticals, inc (ALNY) Q3 2021 Earnings Call Transcript
October 29, 2021
Tickers
ALNY
From Motley Fool
Why Alnylam Pharmaceuticals Stock Is Tanking This Week
October 29, 2021
Tickers
ALNY
From Motley Fool
66 Biggest Movers From Yesterday
October 29, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 28, 2021
From Benzinga
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
3 Top Breakout Stocks to Buy Right Now
October 15, 2021
From Motley Fool
3 Growth Stocks Near 52-Week Highs to Buy Anyway
October 14, 2021
From Motley Fool
Here's Why Inhibrx Stock Is on the Move Today
October 12, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.